Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Ordinary Shares, par value $0.0001 per share
-
Shares outstanding
-
172M
-
Number of holders
-
162
-
Total 13F shares, excl. options
-
61.4M
-
Shares change
-
+2.34M
-
Total reported value, excl. options
-
$2.69B
-
Value change
-
+$109M
-
Put/Call ratio
-
0.8
-
Number of buys
-
94
-
Number of sells
-
-66
-
Price
-
$43.89
Significant Holders of Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (GPCR) as of Q3 2024
221 filings reported holding GPCR - Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share as of Q3 2024.
Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (GPCR) has 162 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 61.4M shares
of 172M outstanding shares and own 35.75% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (7.77M shares), FMR LLC (6.13M shares), JANUS HENDERSON GROUP PLC (3.96M shares), Capital Research Global Investors (3.53M shares), Driehaus Capital Management LLC (2.53M shares), FEDERATED HERMES, INC. (2.41M shares), BVF INC/IL (2.24M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.08M shares), RA CAPITAL MANAGEMENT, L.P. (1.9M shares), and Capital International Investors (1.52M shares).
This table shows the top 162 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.